Search
for
Sort by
Research 61–90 of 501
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Role of liposomal anthracyclines in the treatment of multiple myeloma
- A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.
- Clinical Development of Topoisomerase-Interactive Drugs
- Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
- Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer
- Salvage Chemotherapy in Follicular Non-Hodgkin's Lymphoma: Focus on Tolerability
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- Innovative sequence of docetaxel–gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study
- 2 SIDES OF LUPUS: CASE REPORT
- Non-pharmacological interventions for side effects of antineoplastic chemotherapy prioritized by patients: systematic review
- Managing the adverse effects of cytotoxic chemotherapy at the level of primary healthcare
- An Underrecognized Adverse Effect of Azithromycin
- Three Cases of Hemodialysis Patients with Advanced Gastric Cancer Treated with Paclitaxel and Nab Paclitaxel
- Dermatological drugs, topical agents, and cosmetics
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- КЛІНІЧНІ ФЕНОТИПИ ВИСОКОГО РИЗИКУ НАЯВНОСТІ ПЕРВИННИХ МІТОХОНДРІАЛЬНИХ ЦИТОПАТІЙ (частина 2)
- Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review
- Observational Study of Paclitaxel-Carboplatin versus Pemetrexed-Carboplatin for Advanced Pulmonary Adenocarcinoma at Single-Centre in Indonesia
- 8 / Experimental induction of tenuazonic acid toxicity in mice model
- Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
- Compliance To Medications In Rheumatology Clinic: The Patient Recall As An Indicator
- DRUG NEWS
- Development of PEGylated Liposomes
- Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies
- Coats' Plus: A Progressive Familial Syndrome of Bilateral Coats' Disease, Characteristic Cerebral Calcification, Leukoencephalopathy, Slow Pre- and Post-Natal Linear Growth and Defects of Bone Marrow and Integument
- Photosensitive Trichothiodystrophy with Complex Cerebral Abnormalities